UMP

We are UMP CAS:58-97-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:UMP
CAS.NO:58-97-9
Synonyms:UMP
Uridine monophosphate
5'-Uridylic acid
Uridine 5'-monophosphate
 
Physical and Chemical Properties:
Density 2.2±0.1 g/cm3
Boiling Point 700.1±70.0 °C at 760 mmHg
Melting Point 202 ºC (decomp)
Molecular Formula C9H13N2O9P
Molecular Weight 324.181
Flash Point 377.2±35.7 °C
Exact Mass 324.035858
PSA 181.12000
LogP -1.80
Appearance of Characters solid
Vapour Pressure 0.0±5.0 mmHg at 25°C
Index of Refraction 1.754
Storage condition −20°C
 
Description:
Appearance:White to yellowish powder, hygroscopicity
Assay:≥99.0%
 
Packing:1kg/bag, can also be packaged according to customer requirements
Storage:Keep dry and away from light, sealed storage in -20°C
Use:1. The product is involved in the biosynthesis of glucuronide which is a liver detoxification substance. It can be used to treat liver disease hepatitis as adjuvant drugs and improve the subjective symptoms of coronary heart disease、rheumatic arthritis and leukopenia.
2. This product can be used as nutrition enhancer. It can be added to the milk to increase the amount of nucleotides, make them closer to human milk ingredients , so as to enhance infant’s resistance against bacterial diseases.

UMP


Related News: There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.tributoxymethylsilane There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.octilbenceno CAS:2189-60-8 There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.5-fluoro-6-metilpiridin-2-amina CAS:110919-71-6 There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.

Related Products
Product Name
2-bromo-1-(3,5-difluorophenyl)ethanone View Details
Potassium fluoride Cas:7789-23-3 View Details
CAS:23949-66-8 BASF TINUVIN 312 View Details
L-pipecolate manufacturer Methyl 2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-fluorobenzoate manufacturer Benzyl Glycidyl Ether Cas:89616-40-0 manufacturer Dimethyl aminoterephthalate manufacturer 1,3-difluorobenzene manufacturer